Minimally Invasive Surgery and RhTNK-tPA for Intracerebral Hemorrhage Evacuation
Status:
COMPLETED
Trial end date:
2025-01-27
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine the safety of using a combination of robot-assisted stereotactic puncture and clot lysis with rhTNK-tPA to remove intracerebral hemorrhage (ICH) and to provide dose evidence for a phase III clinical trial.